AI as a Medical Device

Written By

sophie vo Module
Sophie Vo

Associate
UK

I am an Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
green space

A sneak peek into the draft NESRS: What sustainability reporting standards may non-EU parent companies expect?

Dec 24 2024

Read More
Curiosity line yellow background

Australia’s first standalone cyber security law – the Cyber Security Act 2024

Dec 18 2024

Read More
hanging light

Hello there regulation! Implications operators of self-consumption facilities must now deal with following the latest ECJ judgement

Dec 10 2024

Read More